Permanently Discontinued

AURO-MONTELUKAST CHEWABLE TABLET

AURO PHARMA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is AURO-MONTELUKAST CHEWABLE TABLET discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that AURO-MONTELUKAST CHEWABLE TABLET 5MG has been permanently discontinued (last updated December 30, 2023). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is AURO-MONTELUKAST CHEWABLE TABLET not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength5MG

Last updated2023-12-30

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

SINGULAIR

ORGANON CANADA INC.

5MG · DIN 02238216

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

SANDOZ MONTELUKAST

SANDOZ CANADA INCORPORATED

5MG · DIN 02330393

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

VAN-MONTELUKAST

VANC PHARMACEUTICALS INC

5MG · DIN 02427613

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

BIO-MONTELUKAST

BIOMED PHARMA

10MG · DIN 02445735

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

MAR-MONTELUKAST

MARCAN PHARMACEUTICALS INC

10MG · DIN 02399997

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

RATIO-MONTELUKAST

TEVA CANADA LIMITED

4MG · DIN 02336669

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

Montelukast 4 mg chewable tablet

Montelukast chewable tablet; Out of specification

Type II2023-05-12

Moderate health risk

Possible match — not confirmed

DIN

02422875

Strength

5MG

Dosage Form

TABLET (CHEWABLE)

Route

ORAL

Active Ingredient

MONTELUKAST

See all MONTELUKAST products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2023-12-30

Permanently Discontinued

Business reasons

Other Products from AURO PHARMA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02494558

AMPICILLIN SODIUM FOR INJECTION BP

2G · DIN 02462346

AMPICILLIN SODIUM FOR INJECTION BP

500MG · DIN 02462311

AMPICILLIN SODIUM FOR INJECTION BP

1G · DIN 02462338

AMPICILLIN SODIUM FOR INJECTION BP

250MG · DIN 02462303

AURO-ABACAVIR/LAMIVUDINE

DIN 02454513